Merck & Co/MSD has agreed to buy Pandion for ... and is vying to come to market along with other IL-2-based therapies, notably Eli Lilly and Nektar Therapeutics’ phase 2 candidate LY3471851 ...
Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...
President Donald Trump continued to inch the United States toward a trade war Thursday, one with a growing list of opponents. Trump threatened to place a 200% tariff on all alcohol from European ...